-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Coya Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2021 to Q3 2025.
- Coya Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $1.07M, a 38.2% increase year-over-year.
- Coya Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $3.98M, a 88.4% increase year-over-year.
- Coya Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $2.66M, a 205% increase from 2023.
- Coya Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $872K, a 321% increase from 2022.
- Coya Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $207K, a 11.1% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)